In the last trading session, 1.27 million shares of the Tandem Diabetes Care Inc (NASDAQ:TNDM) were traded, and its beta was 1.52. Most recently the company’s share price was $20.22, and it changed around -$0.4 or -1.94% from the last close, which brings the market valuation of the company to $1.34B. TNDM currently trades at a discount to its 52-week high of $53.69, offering almost -165.53% off that amount. The share price’s 52-week low was $17.64, which indicates that the current value has risen by an impressive 12.76% since then. We note from Tandem Diabetes Care Inc’s average daily trading volume that its 10-day average is 1.4 million shares, with the 3-month average coming to 1.51 million.
Tandem Diabetes Care Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.04. If we narrow it down even further, the data shows that 0 out of 25 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 10 recommended TNDM as a Hold, whereas 10 deemed it a Buy, and 1 rated it as Underweight. Tandem Diabetes Care Inc is expected to report earnings per share of -0.6 for the current quarter.
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Instantly TNDM has showed a red trend with a performance of -1.94% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 21.15 on recent trading dayincreased the stock’s daily price by 4.4%. The company’s shares are currently down -43.86% year-to-date, but still up 0.80% over the last five days. On the other hand, Tandem Diabetes Care Inc (NASDAQ:TNDM) is -38.09% down in the 30-day period. We can see from the shorts that 7.14 million shares have been sold at a short interest cover period of 4.39 day(s).
The consensus price target as assigned by Wall Street analysts is $41.5, which translates to bulls needing to increase their stock price by 51.28% from its current value. Analyst projections state that TNDM is forecast to be at a low of $22 and a high of $65.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
The year-over-year growth rate is expected to be 6.22%, up from the previous year.
Consensus estimates provided by 18 financial analysts predict the company will bring in an average of 220.19M in revenue for the current quarter. 18 analysts expect Tandem Diabetes Care Inc to make 245.03M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 191.67M and 221.91M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 14.88%. Forecasts for the next quarter put sales growth at 10.42%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -28.23%. Tandem Diabetes Care Inc earnings are expected to increase by 13.45% in 2025, but the outlook is positive 52.59% per year for the next five years.
TNDM Dividends
Tandem Diabetes Care Inc’s next quarterly earnings report is expected to be released on 2025-Feb-25.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.85% of Tandem Diabetes Care Inc shares, and 110.82% of them are in the hands of institutional investors. The stock currently has a share float of 111.78%. Tandem Diabetes Care Inc stock is held by 437.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 17.1137% of the shares, which is about 11.12 million shares worth $448.14 million.
VANGUARD GROUP INC, with 11.3518% or 7.38 million shares worth $297.26 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Core S&P Small-Cap ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 4.2 shares worth $85.0 million, making up 6.32% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 2.06 shares worth around $41.71 million, which represents about 3.10% of the total shares outstanding.
